SEC Filing Timeline
Recent News (Finnhub)
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders
Should Cronos Group’s Expanded US$50 Million Buyback Shape Capital Allocation Views For Cronos (TSX:CRON) Investors?
Cannabis Stocks Split into Two Camps: Profitable Operators vs. High-Growth Speculation
Cronos Extends a Share Repurchase Program to the Toronto Stock Exchange
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report